Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3709-3715

  Wu, Jingxun ^a   Wu, Xuan ^b   Liang, Wenhua ^b   Chen, Chunling ^a   Zheng, Lingling ^a   An, Hanxiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

CXCR4; Esophageal cancer; Meta analysis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; EMBASE; ESOPHAGUS CANCER; GENDER; HAZARD RATIO; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MEDLINE; META ANALYSIS; METASTASIS; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; PUBLICATION BIAS; RECEPTORS, CXCR4;

EID: 84898779429     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1490-8     Document Type: Article

References (32)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-50.
2. Sugimachi K, Matsuoka H, Ohno S, Mori M, Kuwano H. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br J Surg. 1988;75(11):1115-8.
3. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10-30.
4. Schier AF. Chemokine signaling: rules of attraction. Curr Biol. 2003;13(5):R192-4.
5. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol. 2001;78:57-110.
6. Rottman JB. Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease. Vet Pathol. 1999;36(5):357-67.
7. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (New York, NY). 1996;272(5263):872-7.
8. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006;107(5):1761-7.
9. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol. 2007;292(3):C987-95.
10. Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 2003;5(5):R144-50.
11. Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gonner U, Wilsberg V, et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res. 2005;11(5):1743-50.
12. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 2001;61(13):4961-5.
13. Uchida D, Begum NM, Almofti A, Nakashiro K, Kawamata H, Tateishi Y, et al. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res. 2003;290(2):289-302.
14. Gockel I, Schimanski CC, Heinrich C, Wehler T, Frerichs K, Drescher D, et al. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer. 2006;6:290.
15. Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst. 2005;97(24):1840-7.
16. Lu CL, Guo J, Gu J, Ge D, Hou YY, Lin ZW, et al. CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells. Dis Esophagus. 2013. doi: 10.1111/dote.12100.
17. Lu CL, Ji Y, Ge D, Guo J, Ding JY. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer. Dis Esophagus. 2011;24(4):283-90.
18. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, et al. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Oncol Rep. 2009;21(1):65-71.
19. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, et al. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer. J Surg Oncol. 2008;97(5):433-8.
20. Wang DF, Lou N, Zeng CG, Zhang X, Chen FJ. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. Ai Zheng (Chin J Cancer Res). 2009;28(2):154-8.
21. Zhang L, Ye SB, Ma G, Tang XF, Chen SP, He J, et al. The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma. J Transl Med. 2013;11:60.
22. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
23. Gockel I, Schimanski CC, Moehler M, Junginger T. Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4. Futur Oncol (Lond, Engl). 2007;3(2):119-22.
24. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337(17):1188-94.
25. Sugimachi K, Matsuura H, Kai H, Kanematsu T, Inokuchi K, Jingu K. Prognostic factors of esophageal carcinoma: univariate and multivariate analyses. J Surg Oncol. 1986;31(2):108-12.
26. Almofti A, Uchida D, Begum NM, Tomizuka Y, Iga H, Yoshida H, et al. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int J Oncol. 2004;25(1):65-71.
27. Uchida D, Begum NM, Tomizuka Y, Bando T, Almofti A, Yoshida H, et al. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Investig. 2004;84(12):1538-46.
28. Liotta LA. An attractive force in metastasis. Nature. 2001;410(6824):24-5.
29. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50-6.
30. Gros SJ, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Effenberger K, et al. Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer. PLoS One. 2012;7(10):e47287.
31. Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol. 2007;17(1):38-44.
32. Gockel I, Kneist W, Junginger T. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. World J Surg. 2006;30(2):183-90.